Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition

Henk M W Verheul, Herbert M. Pinedo

Research output: Contribution to journalArticle

Abstract

Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed.

Original languageEnglish (US)
Pages (from-to)475-485
Number of pages11
JournalNature Reviews Cancer
Volume7
Issue number6
DOIs
StatePublished - Jun 2007
Externally publishedYes

Fingerprint

Angiogenesis Inhibitors
Intercellular Signaling Peptides and Proteins
Homeostasis
Clinical Trials
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. / Verheul, Henk M W; Pinedo, Herbert M.

In: Nature Reviews Cancer, Vol. 7, No. 6, 06.2007, p. 475-485.

Research output: Contribution to journalArticle

Verheul, Henk M W ; Pinedo, Herbert M. / Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. In: Nature Reviews Cancer. 2007 ; Vol. 7, No. 6. pp. 475-485.
@article{39c4cb405262436388db6fae4c801711,
title = "Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition",
abstract = "Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed.",
author = "Verheul, {Henk M W} and Pinedo, {Herbert M.}",
year = "2007",
month = "6",
doi = "10.1038/nrc2152",
language = "English (US)",
volume = "7",
pages = "475--485",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition

AU - Verheul, Henk M W

AU - Pinedo, Herbert M.

PY - 2007/6

Y1 - 2007/6

N2 - Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed.

AB - Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed.

UR - http://www.scopus.com/inward/record.url?scp=34249294557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249294557&partnerID=8YFLogxK

U2 - 10.1038/nrc2152

DO - 10.1038/nrc2152

M3 - Article

C2 - 17522716

AN - SCOPUS:34249294557

VL - 7

SP - 475

EP - 485

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 6

ER -